PI3K/Akt/mTOR-IN-2（Cat No.:I043828）is a selective inhibitor targeting the PI3K/Akt/mTOR signaling pathway, which plays a critical role in regulating cell growth, survival, metabolism, and angiogenesis. This pathway is often dysregulated in various cancers and other diseases. By inhibiting key components of the pathway, PI3K/Akt/mTOR-IN-2 suppresses tumor cell proliferation and induces apoptosis. It has shown potential as a therapeutic agent in cancer treatment, particularly for tumors with aberrant PI3K/Akt/mTOR signaling. This inhibitor is valuable in preclinical studies aimed at developing targeted therapies for cancers resistant to conventional treatments.